DK2849760T3 - Fremgangsmåder til oligonukleotid-chelatkompleks - Google Patents

Fremgangsmåder til oligonukleotid-chelatkompleks Download PDF

Info

Publication number: DK2849760T3
Authority: DK; Denmark
Prior art keywords: oligonucleotide; procedures; chelate complex; chelate; complex
Prior art date: 2012-05-18

Application number

DK13791584.9T

Other languages

English (en)

Inventor

Michel Bazinet

Andrew Vaillant

Original Assignee

Replicor Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-05-18

Filing date

2013-05-17

Publication date

2020-02-03

2013-05-17 Application filed by Replicor Inc filed Critical Replicor Inc

2020-02-03 Application granted granted Critical

2020-02-03 Publication of DK2849760T3 publication Critical patent/DK2849760T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7115—Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/712—Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7125—Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Virology (AREA)
Biochemistry (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Neurology (AREA)
Genetics & Genomics (AREA)
Neurosurgery (AREA)
General Engineering & Computer Science (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Zoology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Pulmonology (AREA)
Wood Science & Technology (AREA)
Gastroenterology & Hepatology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Hematology (AREA)

DK13791584.9T 2012-05-18 2013-05-17 Fremgangsmåder til oligonukleotid-chelatkompleks DK2849760T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201261648694P	2012-05-18	2012-05-18
PCT/CA2013/050378 WO2013170385A1 (en)	2012-05-18	2013-05-17	Oligonucleotide chelate complex methods

Publications (1)

Publication Number	Publication Date
DK2849760T3 true DK2849760T3 (da)	2020-02-03

Family

ID=49581827

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK13791584.9T DK2849760T3 (da)	2012-05-18	2013-05-17	Fremgangsmåder til oligonukleotid-chelatkompleks

Country Status (37)

Country	Link
US (1)	US9616083B2 (da)
EP (1)	EP2849760B1 (da)
JP (2)	JP6294308B2 (da)
KR (1)	KR101975915B1 (da)
CN (1)	CN104379152B (da)
AR (1)	AR091065A1 (da)
AU (1)	AU2013262415B2 (da)
BR (1)	BR112014028568B1 (da)
CA (1)	CA2873526C (da)
CL (1)	CL2014003135A1 (da)
CO (1)	CO7131388A2 (da)
CR (1)	CR20140522A (da)
CU (1)	CU20140132A7 (da)
CY (1)	CY1122856T1 (da)
DK (1)	DK2849760T3 (da)
DO (1)	DOP2014000263A (da)
EA (1)	EA034799B1 (da)
EC (1)	ECSP14027542A (da)
ES (1)	ES2767333T3 (da)
HR (1)	HRP20200045T1 (da)
HU (1)	HUE047456T2 (da)
IL (1)	IL235402B (da)
IN (1)	IN2014DN08982A (da)
LT (1)	LT2849760T (da)
MX (1)	MX360626B (da)
MY (1)	MY168209A (da)
NZ (1)	NZ701931A (da)
PH (1)	PH12014502484B1 (da)
PL (1)	PL2849760T3 (da)
PT (1)	PT2849760T (da)
RS (1)	RS59914B1 (da)
SG (1)	SG11201407261XA (da)
SI (1)	SI2849760T1 (da)
SM (1)	SMT202000025T1 (da)
TW (1)	TWI648288B (da)
WO (1)	WO2013170385A1 (da)
ZA (1)	ZA201408082B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2203173B1 (en)	2007-10-26	2015-12-23	Academisch Ziekenhuis Leiden	Means and methods for counteracting muscle disorders
EP2119783A1 (en)	2008-05-14	2009-11-18	Prosensa Technologies B.V.	Method for efficient exon (44) skipping in Duchenne Muscular Dystrophy and associated means
CN112251436A (zh)	2012-01-27	2021-01-22	比奥马林技术公司	治疗杜兴型肌营养不良症和贝克型肌营养不良症的具有改善特性的rna调节性寡核苷酸
KR102025679B1 (ko)	2012-08-30	2019-09-26	레플리코르 인코포레이티드	Ｂ형 간염 및 ｄ형 간염 감염증의 치료 방법
HK1231402A1 (zh) *	2014-07-10	2017-12-22	Replicor Inc.	治疗b型肝炎和d型肝炎病毒感染的方法
US10745687B2 (en)	2015-04-23	2020-08-18	Geron Corporation	Methods of polynucleotide preparation using multivalent cation salt compositions
CA3000931A1 (en)	2015-10-28	2017-05-04	Crispr Therapeutics Ag	Materials and methods for treatment of duchenne muscular dystrophy
SG10202008046UA (en)	2015-12-23	2020-09-29	Univ Queensland Technology	Nucleic acid oligomers and uses therefor
CN109757108A (zh) *	2016-07-05	2019-05-14	比奥马林技术公司	具有治疗遗传疾病的改善特征的包含双环支架部分的前体mRNA剪接转换或调节寡核苷酸
US11166976B2 (en)	2018-11-08	2021-11-09	Aligos Therapeutics, Inc.	S-antigen transport inhibiting oligonucleotide polymers and methods
WO2022229350A2 (en)	2021-04-30	2022-11-03	Tirmed Pharma Ab	Single-stranded oligonucleotides for use in the medical treatment and/or prophylaxis of virus infections

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0691853B1 (en) *	1993-04-01	2002-06-05	Isis Pharmaceuticals, Inc.	ANTISENSE OLIGOS WHICH INTERFERE WITH mRNA CAP ACTIVITY AND INHIBIT TRANSLATION
US20020166764A1 (en)	1997-08-12	2002-11-14	University Of Southern California	Electrochemical sensor devices and methods for fast, reliable, and sensitive detection and quantitation of analytes
US20050020525A1 (en) *	2002-02-20	2005-01-27	Sirna Therapeutics, Inc.	RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
WO2004024919A1 (en) *	2002-09-13	2004-03-25	Replicor, Inc.	Non-sequence complementary antiviral oligonucleotides
CN1694959A (zh) *	2002-09-13	2005-11-09	雷普利瑟公司	非序列互补的抗病毒寡核苷酸
AU2005297376A1 (en) *	2004-10-19	2006-04-27	Replicor Inc.	Antiviral oligonucleotides
WO2007036016A1 (en)	2005-09-29	2007-04-05	Replicor Inc.	Therapeutic molecules and their uses
US8101585B2 (en) *	2006-08-04	2012-01-24	Isis Pharmaceuticals, Inc.	Compositions and methods for the modulation of JNK proteins
WO2009065181A1 (en) *	2007-11-21	2009-05-28	Apollo Life Sciences Limited	Nanostructures suitable for delivery of agents
WO2009109665A1 (en) *	2008-03-07	2009-09-11	Santaris Pharma A/S	Pharmaceutical compositions for treatment of microrna related diseases
WO2010107838A1 (en)	2009-03-16	2010-09-23	Isis Pharmaceuticals, Inc.	Targeting apolipoprotein b for the reduction of apolipoprotein c-iii
CA2764683A1 (en) *	2009-05-28	2010-12-02	Joseph Collard	Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
RS55245B1 (sr) *	2010-08-20	2017-02-28	Replicor Inc	Helatni kompleksi oligonukleotida

2013
- 2013-05-16 AR ARP130101695A patent/AR091065A1/es not_active Application Discontinuation
- 2013-05-17 KR KR1020147035251A patent/KR101975915B1/ko active Active
- 2013-05-17 IN IN8982DEN2014 patent/IN2014DN08982A/en unknown
- 2013-05-17 WO PCT/CA2013/050378 patent/WO2013170385A1/en not_active Ceased
- 2013-05-17 EP EP13791584.9A patent/EP2849760B1/en active Active
- 2013-05-17 SI SI201331646T patent/SI2849760T1/sl unknown
- 2013-05-17 MX MX2014013885A patent/MX360626B/es active IP Right Grant
- 2013-05-17 JP JP2015511876A patent/JP6294308B2/ja not_active Expired - Fee Related
- 2013-05-17 ES ES13791584T patent/ES2767333T3/es active Active
- 2013-05-17 EA EA201401276A patent/EA034799B1/ru unknown
- 2013-05-17 US US13/896,427 patent/US9616083B2/en not_active Expired - Fee Related
- 2013-05-17 CA CA2873526A patent/CA2873526C/en active Active
- 2013-05-17 HR HRP20200045TT patent/HRP20200045T1/hr unknown
- 2013-05-17 SM SM20200025T patent/SMT202000025T1/it unknown
- 2013-05-17 BR BR112014028568-3A patent/BR112014028568B1/pt active IP Right Grant
- 2013-05-17 NZ NZ701931A patent/NZ701931A/en unknown
- 2013-05-17 PL PL13791584T patent/PL2849760T3/pl unknown
- 2013-05-17 SG SG11201407261XA patent/SG11201407261XA/en unknown
- 2013-05-17 HU HUE13791584A patent/HUE047456T2/hu unknown
- 2013-05-17 PT PT137915849T patent/PT2849760T/pt unknown
- 2013-05-17 MY MYPI2014003113A patent/MY168209A/en unknown
- 2013-05-17 LT LTEP13791584.9T patent/LT2849760T/lt unknown
- 2013-05-17 CN CN201380025475.XA patent/CN104379152B/zh active Active
- 2013-05-17 RS RS20200065A patent/RS59914B1/sr unknown
- 2013-05-17 TW TW102117593A patent/TWI648288B/zh active
- 2013-05-17 DK DK13791584.9T patent/DK2849760T3/da active
- 2013-05-17 AU AU2013262415A patent/AU2013262415B2/en active Active
2014
- 2014-10-30 IL IL235402A patent/IL235402B/en unknown
- 2014-11-04 ZA ZA2014/08082A patent/ZA201408082B/en unknown
- 2014-11-06 PH PH12014502484A patent/PH12014502484B1/en unknown
- 2014-11-14 CR CR20140522A patent/CR20140522A/es unknown
- 2014-11-17 CU CU2014000132A patent/CU20140132A7/es unknown
- 2014-11-17 EC ECIEPI201427542A patent/ECSP14027542A/es unknown
- 2014-11-18 DO DO2014000263A patent/DOP2014000263A/es unknown
- 2014-11-18 CL CL2014003135A patent/CL2014003135A1/es unknown
- 2014-11-19 CO CO14254326A patent/CO7131388A2/es unknown
2017
- 2017-11-02 JP JP2017212508A patent/JP2018058853A/ja active Pending
2020
- 2020-01-21 CY CY20201100051T patent/CY1122856T1/el unknown

Also Published As

Publication number	Publication date
TWI648288B (zh)	2019-01-21
CL2014003135A1 (es)	2015-01-09
ECSP14027542A (es)	2015-12-31
TW201408689A (zh)	2014-03-01
JP2015517503A (ja)	2015-06-22
CR20140522A (es)	2014-12-10
BR112014028568B1 (pt)	2022-02-15
JP2018058853A (ja)	2018-04-12
CU20140132A7 (es)	2015-02-26
KR101975915B1 (ko)	2019-05-08
MY168209A (en)	2018-10-15
ZA201408082B (en)	2015-12-23
SMT202000025T1 (it)	2020-03-13
BR112014028568A2 (pt)	2020-06-02
EA201401276A1 (ru)	2015-04-30
LT2849760T (lt)	2020-04-10
HUE047456T2 (hu)	2020-04-28
CN104379152B (zh)	2018-10-30
US9616083B2 (en)	2017-04-11
AU2013262415A1 (en)	2014-11-27
PT2849760T (pt)	2020-01-24
RS59914B1 (sr)	2020-03-31
IL235402A0 (en)	2014-12-31
PH12014502484A1 (en)	2015-01-12
ES2767333T3 (es)	2020-06-17
AR091065A1 (es)	2014-12-30
SI2849760T1 (sl)	2020-03-31
MX2014013885A (es)	2015-05-08
CA2873526C (en)	2020-08-18
CO7131388A2 (es)	2014-12-01
HRP20200045T1 (hr)	2020-03-20
IN2014DN08982A (da)	2015-05-22
EP2849760B1 (en)	2019-10-30
AU2013262415B2 (en)	2017-06-22
CA2873526A1 (en)	2013-11-21
EP2849760A4 (en)	2015-03-25
SG11201407261XA (en)	2014-12-30
US20130310445A1 (en)	2013-11-21
CY1122856T1 (el)	2021-05-05
WO2013170385A1 (en)	2013-11-21
EP2849760A1 (en)	2015-03-25
MX360626B (es)	2018-11-12
IL235402B (en)	2022-01-01
EA034799B1 (ru)	2020-03-23
PH12014502484B1 (en)	2021-03-31
HK1206259A1 (en)	2016-01-08
CN104379152A (zh)	2015-02-25
PL2849760T3 (pl)	2020-05-18
KR20150016330A (ko)	2015-02-11
NZ701931A (en)	2016-06-24
JP6294308B2 (ja)	2018-03-14
DOP2014000263A (es)	2015-01-31

Publication	Publication Date	Title
EP2763896A4 (en)	2015-03-11	UNMANUFACTURED AIRCRAFT WITH SEVERAL ROTORS
DK2859055T3 (da)	2021-02-22	Polymercoatings
EP2880683A4 (en)	2016-03-30	BVA INTERPOSER
DK2825087T3 (da)	2019-05-13	Otoscanner
EP2809145A4 (en)	2015-09-16	CHLOROPLAST TRANSIT PEPTIDES
DK2839013T3 (da)	2020-09-14	Ikke-disruptiv-gen-targetering
EP2814472A4 (en)	2015-11-04	DITHIOAMINE REDUCING AGENTS
EP2824794A4 (en)	2016-02-24	Charging cable
EP2847405A4 (en)	2016-03-02	DOOR CLOSURE SYSTEM
EP2805877A4 (en)	2015-09-09	UNDER HOOD
DK2873977T3 (da)	2020-06-08	Dobbeltdækker-rørdispenser
DE112012006109A5 (de)	2014-12-18	Okklusionsschienenanordnung
DK2854722T3 (da)	2020-08-24	Stomipose
EP2941099A4 (en)	2016-08-24	SWITCHING DEVICE
EP2816694A4 (en)	2015-10-28	FLAT CABLE WINDING DEVICE
DK2825157T3 (da)	2019-01-02	Aminosyrelipider
EP2812047A4 (en)	2015-10-21	ACCESS SYSTEM VIA AN OCCLUSION
DK2849760T3 (da)	2020-02-03	Fremgangsmåder til oligonukleotid-chelatkompleks
EP2809729A4 (en)	2015-09-02	Siloxane polyether copolymers
EP2862179A4 (en)	2016-06-01	FUEL CURRENT INSPECTION PROBE
EP2869113A4 (en)	2015-12-02	DISPLAY DEVICE FOR VEHICLE
EP2801315A4 (en)	2015-09-09	SCANNING ENDOSCOPE DEVICE
DK2831122T3 (da)	2016-05-17	Anthocyanidin-kompleks
DE112012006214T8 (de)	2015-04-16	Wulstringwickler
DE112012005566T8 (de)	2014-11-13	Seltenerdnanoverbundmagnet